Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 15, Number 6—June 2009

Dispatch

Leishmaniasis, Autoimmune Rheumatic Disease, and Anti–Tumor Necrosis Factor Therapy, Europe

Ioannis D. Xynos, Maria G. Tektonidou, Dimitrios Pikazis, and Nikolaos V. SipsasComments to Author 
Author affiliations: National and Kapodistrian University of Athens, Athens, Greece (I.D. Xynos, D. Pikazis, N.V. Sipsas); Euroclinic Hospital of Athens, Athens (M.G. Tektonidou)

Main Article

Figure

Reported cases of leishmaniasis in patients with autoimmune rheumatic diseases in Europe, indicated by stars (1 case from Israel not shown). Dark gray shading, distribution of leishmaniasis; light gray shading, distribution of leishmaniasis vector sandfly. Source: World Health Organization, 2004 (www.who.int/tdr/svc/publications/tdr-research-publications/swg-report-leishmaniasis).

Figure. Reported cases of leishmaniasis in patients with autoimmune rheumatic diseases in Europe, indicated by stars (1 case from Israel not shown). Dark gray shading, distribution of leishmaniasis; light gray shading, distribution of leishmaniasis vector sandfly. Source: World Health Organization, 2004 (www.who.int/tdr/svc/publications/tdr-research-publications/swg-report-leishmaniasis).

Main Article

TOP